Leonor is an emerging, young journalist who writes daily for BioNews Texas, covering business, science, and health news. She holds a bachelor’s degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.
Trevena, Inc. has been granted a U.S. patent for TRV734, its investigational treatment for acute and chronic moderate-to-severe pain, as well as compositions comprising TRV734, and methods of using TRV734. The U.S. ... Read more
Pfizer recently failed to meet the primary endpoint of its phase 4 study to evaluate a treatment for fibromyalgia in adolescents, called Lyrica (pregabalin) Capsules CV. The company announced in a press release ... Read more
Clinical-stage biopharmaceutical company, Nektar Therapeutics, is currently studying a novel drug therapy for chronic pain that may impact the current treatment of fibromyalgia. The drug called NKTR-181 is expected to relieve ... Read more
Premier Biomedical Inc. has announced it will submit an application to the U.S. Food and Drug Administration (FDA) with the purpose of selling an exclusively licensed and patented drug therapy ... Read more
AVACEN Medical is launching a campaign on Crowdfunder.com to help raise $2 million and support the development of an investigational therapy for fibromyalgia, as well as its application to the U.S. Food and ... Read more
Chronic pain and fatigue, typical symptoms of fibromyalgia syndrome (FMS), may be treated with vitamin D supplements as an alternative or adjunct to other treatment, as found by researchers working ... Read more
Pin It on Pinterest